Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.

Health technology assessment (Winchester, England)

Volumn 7, Issue 15, 2003, Pages 1-136

  Boland, A ^a   Dundar, Y ^b   Bagust, A ^b   Haycox, A ^b   Hill, R ^b   Mujica Mota, R ^b   Walley, T ^b   Dickson, R ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

CLASSIFICATION; COST BENEFIT ANALYSIS; DRUG SCREENING; ECONOMICS; EMERGENCY TREATMENT; FIBRINOLYTIC THERAPY; HEART INFARCTION; HOSPITALIZATION; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TIME; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; DRUG EVALUATION; EMERGENCY TREATMENT; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; STREPTOKINASE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84891618504     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta7150     Document Type: Review

References (130)